Velarion · Company Intelligence
Compensation Brief
Fiscal year 2024 · Filings through 2026-03-05

RAPT Therapeutics (RAPT)

CEO Brian Wong was paid $6,979,539 in fiscal year 2024, ↑ up 5.9% from fiscal year 2023 (SEC filing 0000950170-25-053517 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$6,979,539 ↑
Brian Wong total, FY2024
—
CEO pay percentile vs peers
—
CEO-to-median pay ratio
76.48%
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Brian Wong (President and Chief Executive Officer), FY2024 total compensation $6,979,539 (base salary $630,000) [exec_comp, SEC accession 0000950170-25-053517, filed 2025-04-14]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

01

Summary Compensation Table — fiscal year 2024

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Brian Wong$630,000$0$0$5,927,297$416,000$0$6,242$6,979,539
President and Chief Executive Officer
Rodney Young478,000001,975,492229,44008,5642,691,496
Chief Financial Officer
William Ho481,000001,603,438221,26007,3222,313,020
Chief Medical Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2024 totalFY2023 totalFY2022 totalΔ FY2023→2024
Brian Wong$6,979,539$6,591,617—↑ +387,922
Rodney Young2,691,4962,175,226—↑ +516,270
William Ho2,313,0201,903,926—↑ +409,094

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read RAPT Therapeutics's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper RAPT reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

How we handle your data → Privacy

Companies that benchmark against RAPT
12 companies name RAPT as a compensation peer

Each company listed discloses RAPT in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named RAPT in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2024 total
Linda KozickIndependent Director$191,919
Lori Lyons-WilliamsChair of the Board$194,294
Mary Ann GrayIndependent Director$207,419
Michael GiordanoIndependent Director$201,419
Wendye RobbinsIndependent Director$194,919
William RieflinFormer director (through FY2024)$232,419
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2024 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Linda KozickDirector2025-05-29A257,832$0$0Derivative, Class A CommonForm 4 ↗
Lori Lyons-WilliamsDirector2025-05-29A257,83200Derivative, Class A CommonForm 4 ↗
Michael GiordanoDirector2025-05-29A257,83200Derivative, Class A CommonForm 4 ↗
Mary Ann GrayDirector2025-05-29A257,83200Derivative, Class A CommonForm 4 ↗
Dirk G. BrockstedtCHIEF SCIENTIFIC OFFICER2025-06-20A100,00000Derivative, Class A CommonForm 4 ↗
Rodney YoungCHIEF FINANCIAL OFFICER2025-06-20A118,75000Derivative, Class A CommonForm 4 ↗
Brian WongDirector2025-06-20A637,50000Derivative, Class A CommonForm 4 ↗
William HoCHIEF MEDICAL OFFICER2025-06-20A75,00000Derivative, Class A CommonForm 4 ↗
Scott BraunsteinDirector2025-06-21A25,00000Derivative, Class A CommonForm 4 ↗
Ashley L. DombkowskiDirector2025-06-21A25,00000Derivative, Class A CommonForm 4 ↗
Ashley L. DombkowskiDirector2026-01-30A4,95600CommonForm 4 ↗
Linda KozickDirector2026-01-30A4,95600CommonForm 4 ↗
Mary Ann GrayDirector2026-01-30A4,95600CommonForm 4 ↗
Lori Lyons-WilliamsDirector2026-01-30A4,95600CommonForm 4 ↗
Michael GiordanoDirector2026-01-30A4,95600CommonForm 4 ↗
Scott BraunsteinDirector2026-01-30A4,95600CommonForm 4 ↗
Michael GiordanoDirector2026-03-03D402——Derivative, Class A CommonForm 4 ↗
Mary Ann GrayDirector2026-03-03D4,956——CommonForm 4 ↗
Mary Ann GrayDirector2026-03-03D498——Derivative, Class A CommonForm 4 ↗
Mary Ann GrayDirector2026-03-03D2,813——Derivative, Class A CommonForm 4 ↗
Linda KozickDirector2026-03-03D4,956——CommonForm 4 ↗
Brian WongDirector2026-03-03D64,102——CommonForm 4 ↗
Dirk G. BrockstedtCHIEF SCIENTIFIC OFFICER2026-03-03D2,500——Derivative, Class A CommonForm 4 ↗
Rodney YoungCHIEF FINANCIAL OFFICER2026-03-03D80,250——Derivative, Class A CommonForm 4 ↗
Scott BraunsteinDirector2026-03-03D25,000——Derivative, Class A CommonForm 4 ↗
Linda KozickDirector2026-03-03D417——Derivative, Class A CommonForm 4 ↗
Linda KozickDirector2026-03-03D521——Derivative, Class A CommonForm 4 ↗
Brian WongDirector2026-03-03D31,250——Derivative, Class A CommonForm 4 ↗
Dirk G. BrockstedtCHIEF SCIENTIFIC OFFICER2026-03-03D4,648——CommonForm 4 ↗
Rodney YoungCHIEF FINANCIAL OFFICER2026-03-03D69,271——Derivative, Class A CommonForm 4 ↗
Mary Ann GrayDirector2026-03-03D938——Derivative, Class A CommonForm 4 ↗
Mary Ann GrayDirector2026-03-03D478——Derivative, Class A CommonForm 4 ↗
Mary Ann GrayDirector2026-03-03D938——Derivative, Class A CommonForm 4 ↗
Lori Lyons-WilliamsDirector2026-03-03D32,229——Derivative, Class A CommonForm 4 ↗
Lori Lyons-WilliamsDirector2026-03-03D1,063——Derivative, Class A CommonForm 4 ↗
Lori Lyons-WilliamsDirector2026-03-03D2,813——Derivative, Class A CommonForm 4 ↗
Lori Lyons-WilliamsDirector2026-03-03D4,956——CommonForm 4 ↗
Lori Lyons-WilliamsDirector2026-03-03D1,618——Derivative, Class A CommonForm 4 ↗
Lori Lyons-WilliamsDirector2026-03-03D4,561——Derivative, Class A CommonForm 4 ↗
Michael GiordanoDirector2026-03-03D32,229——Derivative, Class A CommonForm 4 ↗
Michael GiordanoDirector2026-03-03D1,618——Derivative, Class A CommonForm 4 ↗
Michael GiordanoDirector2026-03-03D1,063——Derivative, Class A CommonForm 4 ↗
Michael GiordanoDirector2026-03-03D938——Derivative, Class A CommonForm 4 ↗
Michael GiordanoDirector2026-03-03D4,956——CommonForm 4 ↗
Linda KozickDirector2026-03-03D1,917——Derivative, Class A CommonForm 4 ↗
Linda KozickDirector2026-03-03D32,229——Derivative, Class A CommonForm 4 ↗
Linda KozickDirector2026-03-03D4,561——Derivative, Class A CommonForm 4 ↗
Linda KozickDirector2026-03-03D1,618——Derivative, Class A CommonForm 4 ↗
Linda KozickDirector2026-03-03D938——Derivative, Class A CommonForm 4 ↗
Linda KozickDirector2026-03-03D938——Derivative, Class A CommonForm 4 ↗
Linda KozickDirector2026-03-03D521——Derivative, Class A CommonForm 4 ↗
Linda KozickDirector2026-03-03D2,083——Derivative, Class A CommonForm 4 ↗
Mary Ann GrayDirector2026-03-03D560——Derivative, Class A CommonForm 4 ↗
Mary Ann GrayDirector2026-03-03D32,229——Derivative, Class A CommonForm 4 ↗
Mary Ann GrayDirector2026-03-03D7,650——Derivative, Class A CommonForm 4 ↗
Mary Ann GrayDirector2026-03-03D4,561——Derivative, Class A CommonForm 4 ↗
Mary Ann GrayDirector2026-03-03D1,072——Derivative, Class A CommonForm 4 ↗
Mary Ann GrayDirector2026-03-03D1,618——Derivative, Class A CommonForm 4 ↗
Mary Ann GrayDirector2026-03-03D1,063——Derivative, Class A CommonForm 4 ↗
Mary Ann GrayDirector2026-03-03D484——Derivative, Class A CommonForm 4 ↗
Scott BraunsteinDirector2026-03-03D4,956——CommonForm 4 ↗
Linda KozickDirector2026-03-03D1,063——Derivative, Class A CommonForm 4 ↗
Brian WongDirector2026-03-03D371,875——Derivative, Class A CommonForm 4 ↗
Brian WongDirector2026-03-03D218,250——Derivative, Class A CommonForm 4 ↗
Brian WongDirector2026-03-03D34,375——Derivative, Class A CommonForm 4 ↗
Brian WongDirector2026-03-03D37,500——Derivative, Class A CommonForm 4 ↗
Brian WongDirector2026-03-03D18,750——Derivative, Class A CommonForm 4 ↗
Brian WongDirector2026-03-03D7,500——Derivative, Class A CommonForm 4 ↗
Brian WongDirector2026-03-03D10,417——Derivative, Class A CommonForm 4 ↗
Brian WongDirector2026-03-03D8,334——Derivative, Class A CommonForm 4 ↗
Brian WongDirector2026-03-03D25,000——Derivative, Class A CommonForm 4 ↗
Dirk G. BrockstedtCHIEF SCIENTIFIC OFFICER2026-03-03D58,333——Derivative, Class A CommonForm 4 ↗
Dirk G. BrockstedtCHIEF SCIENTIFIC OFFICER2026-03-03D64,375——Derivative, Class A CommonForm 4 ↗
Dirk G. BrockstedtCHIEF SCIENTIFIC OFFICER2026-03-03D9,375——Derivative, Class A CommonForm 4 ↗
Dirk G. BrockstedtCHIEF SCIENTIFIC OFFICER2026-03-03D7,000——Derivative, Class A CommonForm 4 ↗
Dirk G. BrockstedtCHIEF SCIENTIFIC OFFICER2026-03-03D6,876——Derivative, Class A CommonForm 4 ↗
Dirk G. BrockstedtCHIEF SCIENTIFIC OFFICER2026-03-03D6,250——Derivative, Class A CommonForm 4 ↗
Dirk G. BrockstedtCHIEF SCIENTIFIC OFFICER2026-03-03D3,125——Derivative, Class A CommonForm 4 ↗
Dirk G. BrockstedtCHIEF SCIENTIFIC OFFICER2026-03-03D1,035——Derivative, Class A CommonForm 4 ↗
Dirk G. BrockstedtCHIEF SCIENTIFIC OFFICER2026-03-03D1,225——Derivative, Class A CommonForm 4 ↗
Rodney YoungCHIEF FINANCIAL OFFICER2026-03-03D11,251——Derivative, Class A CommonForm 4 ↗
Rodney YoungCHIEF FINANCIAL OFFICER2026-03-03D8,501——Derivative, Class A CommonForm 4 ↗
Rodney YoungCHIEF FINANCIAL OFFICER2026-03-03D8,125——Derivative, Class A CommonForm 4 ↗
Rodney YoungCHIEF FINANCIAL OFFICER2026-03-03D7,500——Derivative, Class A CommonForm 4 ↗
Rodney YoungCHIEF FINANCIAL OFFICER2026-03-03D17,501——Derivative, Class A CommonForm 4 ↗
Rodney YoungCHIEF FINANCIAL OFFICER2026-03-03D3,304——CommonForm 4 ↗
Ashley L. DombkowskiDirector2026-03-03D25,000——Derivative, Class A CommonForm 4 ↗
Ashley L. DombkowskiDirector2026-03-03D4,956——CommonForm 4 ↗
Michael GiordanoDirector2026-03-03D4,561——Derivative, Class A CommonForm 4 ↗
Michael GiordanoDirector2026-03-03D938——Derivative, Class A CommonForm 4 ↗
Michael GiordanoDirector2026-03-03D799——Derivative, Class A CommonForm 4 ↗
Michael GiordanoDirector2026-03-03D824——Derivative, Class A CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

04

Outstanding equity awards at fiscal year-end 2024

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Rodney YoungRSU47,395—$17,605
Brian WongRSU119,791—44,494
William HoRSU40,104—14,896
Brian WongRSU146,875—54,554
Brian WongRSU218,750—81,250
Rodney YoungRSU140,000—52,003
Brian WongRSU83,333—30,952
Brian WongRSU63,020—23,407
Rodney YoungRSU58,750—21,823
Rodney YoungRSU32,583—12,103
Brian WongRSU60,000—22,286
William HoRSU53,854—20,003
William HoRSU26,833—9,967
Rodney YoungRSU20,635—7,665
William HoRSU20,000—7,429
William HoRSU17,187—6,384
William HoRSU7,807—2,900
05

Incentive-plan design — the Compensation Discussion & Analysis

We have a pay-for-performance focused executive compensation philosophy designed to drive company performance aimed at increasing stockholder value. We seek to achieve this by using a market-based approach to attract, retain, and motivate a high-performing team of executive officers and by aligning most of the compensation of each of our executives with the Company’s short- and long-term performance, as well as each such executive’s individual contributions.

CEO STI target (% of salary)55%
CEO LTI target (% of salary)—
Independent consultantAon plc/Radford
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingtrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20252025-05-2976,867,72223,639,12555,52776.48%Passed
20242024-05-22—————

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20252025-05-2976.48%a
20242024-05-22—b

a. Voting standard not stated in the filing.

b. Voting standard not stated in the filing.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

08

Director compensation — fiscal year 2024

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
William RieflinIndependent$90,000$0$142,419—$0$232,419
Mary Ann GrayIndependent · Audit (Chair)65,0000142,419—0207,419
Michael GiordanoIndependent · Compensation (Chair) · Nominating and Corporate Governance59,0000142,419—0201,419
Wendye RobbinsIndependent · Audit · Not standing for re-election52,5000142,419—0194,919
Lori Lyons-WilliamsIndependent · Board Chair · Compensation · Nominating and Corporate Governance51,8750142,419—0194,294
Linda KozickIndependent · Audit · Nominating and Corporate Governance (Chair)49,5000142,419—0191,919
Brian WongEmployee director000—00
09

Board fee structure and ownership guideline

Annual cash retainer$40,000
Annual equity retainer$200,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)25,000 / 15,000 / 10,000
Stock ownership guideline—
09b

Total cost of the board

ComponentFY2024
Cash retainers and fees$367,875
Equity awards (grant-date value)$0
All other compensation$0
Total cost of the board$367,875

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1RAPT Therapeutics2024Brian Wong$630,000$0$5,927,297$416,000$6,979,539

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10d

Frequently asked questions

Who was the highest-paid executive at RAPT Therapeutics in fiscal 2024?
As disclosed, Brian Wong (President and Chief Executive Officer) was the highest-paid executive at RAPT Therapeutics in fiscal 2024, with total compensation of $6,979,539.
How did shareholders vote on RAPT Therapeutics's executive compensation?
As disclosed, 76.48% of shareholders supported RAPT Therapeutics's executive compensation in the latest say-on-pay vote.
How much does RAPT Therapeutics spend in total on board compensation for fiscal 2024?
As disclosed, RAPT Therapeutics reported total board compensation of $367,875 for fiscal 2024.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Brian WongDEF 14A2025-04-140000950170-25-053517Section “Executive Compensation”. As printed: 6,979,539. Filing ↗machine: r2 · c23 · span 816852–816861
2Section 01, Rodney YoungDEF 14A2025-04-140000950170-25-053517Section “Executive Compensation”. As printed: 2,691,496. Filing ↗machine: r6 · c23 · span 849443–849452
3Section 01, William HoDEF 14A2025-04-140000950170-25-053517Section “Executive Compensation”. As printed: 2,313,020. Filing ↗machine: r4 · c23 · span 833172–833181
4Section 08, William RieflinDEF 14A2025-04-140000950170-25-053517Section “Director Compensation”. As printed: 232,419. Filing ↗machine: span 1108600–1108809
5Section 08, Mary Ann GrayDEF 14A2025-04-140000950170-25-053517Section “Director Compensation”. As printed: 207,419. Filing ↗machine: span 1118925–1119134
6Section 08, Michael GiordanoDEF 14A2025-04-140000950170-25-053517Section “Director Compensation”. As printed: 201,419. Filing ↗machine: span 1113762–1113971
7Section 08, Wendye RobbinsDEF 14A2025-04-140000950170-25-053517Section “Director Compensation”. As printed: 194,919. Filing ↗machine: span 1129240–1129449
8Section 08, Lori Lyons-WilliamsDEF 14A2025-04-140000950170-25-053517Section “Director Compensation”. As printed: 194,294. Filing ↗machine: span 1134399–1134608
9Section 08, Linda KozickDEF 14A2025-04-140000950170-25-053517Section “Director Compensation”. As printed: 191,919. Filing ↗machine: span 1124077–1124286
10Section 08, Brian WongDEF 14A2025-04-140000950170-25-053517Section “Director Compensation”. As printed: 0. Filing ↗
11Section 02, Linda Kozick 2025-05-29Form 42025-06-020001415889-25-015196Insider equity transaction reported since the proxy statement. Filing ↗
12Section 02, Lori Lyons-Williams 2025-05-29Form 42025-06-020001415889-25-015216Insider equity transaction reported since the proxy statement. Filing ↗
13Section 02, Michael Giordano 2025-05-29Form 42025-06-020001415889-25-015230Insider equity transaction reported since the proxy statement. Filing ↗
14Section 02, Mary Ann Gray 2025-05-29Form 42025-06-020001415889-25-015224Insider equity transaction reported since the proxy statement. Filing ↗
15Section 02, Dirk G. Brockstedt 2025-06-20Form 42025-06-240001415889-25-018062Insider equity transaction reported since the proxy statement. Filing ↗
16Section 02, Rodney Young 2025-06-20Form 42025-06-240001415889-25-018063Insider equity transaction reported since the proxy statement. Filing ↗
17Section 02, Brian Wong 2025-06-20Form 42025-06-240001415889-25-018067Insider equity transaction reported since the proxy statement. Filing ↗
18Section 02, William Ho 2025-06-20Form 42025-06-240001415889-25-018072Insider equity transaction reported since the proxy statement. Filing ↗
19Section 02, Scott Braunstein 2025-06-21Form 42025-06-240001415889-25-018080Insider equity transaction reported since the proxy statement. Filing ↗
20Section 02, Ashley L. Dombkowski 2025-06-21Form 42025-06-300001415889-25-018579Insider equity transaction reported since the proxy statement. Filing ↗
21Section 02, Ashley L. Dombkowski 2026-01-30Form 42026-02-020001270774-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
22Section 02, Linda Kozick 2026-01-30Form 42026-02-020001782274-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
23Section 02, Mary Ann Gray 2026-01-30Form 42026-02-020001261974-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
24Section 02, Lori Lyons-Williams 2026-01-30Form 42026-02-020001693564-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
25Section 02, Michael Giordano 2026-01-30Form 42026-02-020001733915-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
26Section 02, Scott Braunstein 2026-01-30Form 42026-02-020001643875-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
27Section 02, Michael Giordano 2026-03-03Form 42026-03-050001733915-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
28Section 02, Mary Ann Gray 2026-03-03Form 42026-03-050001261974-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
29Section 02, Mary Ann Gray 2026-03-03Form 42026-03-050001261974-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, Mary Ann Gray 2026-03-03Form 42026-03-050001261974-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, Linda Kozick 2026-03-03Form 42026-03-050001782274-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, Brian Wong 2026-03-03Form 42026-03-050001646110-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, Dirk G. Brockstedt 2026-03-03Form 42026-03-050001635616-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, Rodney Young 2026-03-03Form 42026-03-050001337831-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, Scott Braunstein 2026-03-03Form 42026-03-050001643875-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, Linda Kozick 2026-03-03Form 42026-03-050001782274-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Linda Kozick 2026-03-03Form 42026-03-050001782274-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Brian Wong 2026-03-03Form 42026-03-050001646110-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Dirk G. Brockstedt 2026-03-03Form 42026-03-050001635616-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Rodney Young 2026-03-03Form 42026-03-050001337831-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Mary Ann Gray 2026-03-03Form 42026-03-050001261974-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Mary Ann Gray 2026-03-03Form 42026-03-050001261974-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Mary Ann Gray 2026-03-03Form 42026-03-050001261974-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Lori Lyons-Williams 2026-03-03Form 42026-03-050001693564-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Lori Lyons-Williams 2026-03-03Form 42026-03-050001693564-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Lori Lyons-Williams 2026-03-03Form 42026-03-050001693564-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Lori Lyons-Williams 2026-03-03Form 42026-03-050001693564-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Lori Lyons-Williams 2026-03-03Form 42026-03-050001693564-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Lori Lyons-Williams 2026-03-03Form 42026-03-050001693564-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Michael Giordano 2026-03-03Form 42026-03-050001733915-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Michael Giordano 2026-03-03Form 42026-03-050001733915-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Michael Giordano 2026-03-03Form 42026-03-050001733915-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Michael Giordano 2026-03-03Form 42026-03-050001733915-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, Michael Giordano 2026-03-03Form 42026-03-050001733915-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Linda Kozick 2026-03-03Form 42026-03-050001782274-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Linda Kozick 2026-03-03Form 42026-03-050001782274-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Linda Kozick 2026-03-03Form 42026-03-050001782274-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Linda Kozick 2026-03-03Form 42026-03-050001782274-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Linda Kozick 2026-03-03Form 42026-03-050001782274-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Linda Kozick 2026-03-03Form 42026-03-050001782274-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Linda Kozick 2026-03-03Form 42026-03-050001782274-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Linda Kozick 2026-03-03Form 42026-03-050001782274-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Mary Ann Gray 2026-03-03Form 42026-03-050001261974-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Mary Ann Gray 2026-03-03Form 42026-03-050001261974-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Mary Ann Gray 2026-03-03Form 42026-03-050001261974-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Mary Ann Gray 2026-03-03Form 42026-03-050001261974-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Mary Ann Gray 2026-03-03Form 42026-03-050001261974-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Mary Ann Gray 2026-03-03Form 42026-03-050001261974-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Mary Ann Gray 2026-03-03Form 42026-03-050001261974-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Mary Ann Gray 2026-03-03Form 42026-03-050001261974-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Scott Braunstein 2026-03-03Form 42026-03-050001643875-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, Linda Kozick 2026-03-03Form 42026-03-050001782274-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Brian Wong 2026-03-03Form 42026-03-050001646110-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Brian Wong 2026-03-03Form 42026-03-050001646110-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Brian Wong 2026-03-03Form 42026-03-050001646110-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, Brian Wong 2026-03-03Form 42026-03-050001646110-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
77Section 02, Brian Wong 2026-03-03Form 42026-03-050001646110-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
78Section 02, Brian Wong 2026-03-03Form 42026-03-050001646110-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
79Section 02, Brian Wong 2026-03-03Form 42026-03-050001646110-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
80Section 02, Brian Wong 2026-03-03Form 42026-03-050001646110-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
81Section 02, Brian Wong 2026-03-03Form 42026-03-050001646110-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
82Section 02, Dirk G. Brockstedt 2026-03-03Form 42026-03-050001635616-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
83Section 02, Dirk G. Brockstedt 2026-03-03Form 42026-03-050001635616-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
84Section 02, Dirk G. Brockstedt 2026-03-03Form 42026-03-050001635616-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
85Section 02, Dirk G. Brockstedt 2026-03-03Form 42026-03-050001635616-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
86Section 02, Dirk G. Brockstedt 2026-03-03Form 42026-03-050001635616-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
87Section 02, Dirk G. Brockstedt 2026-03-03Form 42026-03-050001635616-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
88Section 02, Dirk G. Brockstedt 2026-03-03Form 42026-03-050001635616-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
89Section 02, Dirk G. Brockstedt 2026-03-03Form 42026-03-050001635616-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
90Section 02, Dirk G. Brockstedt 2026-03-03Form 42026-03-050001635616-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
91Section 02, Rodney Young 2026-03-03Form 42026-03-050001337831-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
92Section 02, Rodney Young 2026-03-03Form 42026-03-050001337831-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
93Section 02, Rodney Young 2026-03-03Form 42026-03-050001337831-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
94Section 02, Rodney Young 2026-03-03Form 42026-03-050001337831-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
95Section 02, Rodney Young 2026-03-03Form 42026-03-050001337831-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
96Section 02, Rodney Young 2026-03-03Form 42026-03-050001337831-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
97Section 02, Ashley L. Dombkowski 2026-03-03Form 42026-03-050001270774-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
98Section 02, Ashley L. Dombkowski 2026-03-03Form 42026-03-050001270774-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
99Section 02, Michael Giordano 2026-03-03Form 42026-03-050001733915-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
100Section 02, Michael Giordano 2026-03-03Form 42026-03-050001733915-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
101Section 02, Michael Giordano 2026-03-03Form 42026-03-050001733915-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
102Section 02, Michael Giordano 2026-03-03Form 42026-03-050001733915-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
103Section 06, 2025 voteForm 8-K2025-05-290000950170-25-079023Item 5.07 · say-on-pay result. As reported: 76.48% (votes for as printed: 76,867,722). Filing ↗
104Section 06, 2024 voteForm 8-K2024-05-230000950170-24-064001Item 5.07 · say-on-pay result. As reported: —. Filing ↗
105Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
106Section 09b board cost (computed)Computed——Cash 367,875 + equity 0 + all other 0 = 367,875, summed across the director compensation table rows.machine: formula: Σ = 367,875
107RAPT Therapeutics (subject), Section 10b CEO totalDEF 14A2025-04-140000950170-25-053517CEO total compensation as printed in RAPT Therapeutics's own proxy. As printed: 6,979,539. Filing ↗machine: r2 · c23 · span 816852–816861

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.